Azoxybacilin
Alternative Names: RO 091563Latest Information Update: 21 Jun 2000
Price :
$50 *
At a glance
- Originator Chugai Pharmaceutical
- Class Antifungals
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 21 Jun 2000 Discontinued-Preclinical for Mycoses in Japan (Unknown route)
- 12 Oct 1998 No-Development-Reported for Mycoses in Japan (Unknown route)
- 19 Apr 1996 Preclinical development for Mycoses in Japan (Unknown route)